Infectious Disease
In Under 25s, Racial, Ethnic Disparities in COVID-19 Incidence Varied
Largest persistent disparities seen for NH/PI, AI/AN, and Hispanic or Latino persons from January to December 2020
Physician’s Briefing Weekly Coronavirus Roundup
Over Half Have Symptoms of Major Depressive Disorder After COVID-19
Presence of headache and greater overall severity linked to increased odds of moderate or greater depression symptoms
Novavax COVID-19 Vaccine Highly Effective in Clinical Trials
Company will present the data to regulatory agencies worldwide, including the FDA
Pfizer COVID-19 Vaccine 97 Percent Effective Against Symptomatic Disease
Analysis of data from Israel's vaccination campaign also showed vaccine to be 94 percent effective against asymptomatic disease
Rates of Acute Allergic Reactions to COVID-19 Vaccines Extremely Low
Most recipients with anaphylaxis had allergy histories, with 31 percent having prior anaphylaxis
Decline in Kidney Function Faster After COVID-19-Related AKI
Among patients who have in-hospital acute kidney injury, those with AKI tied to COVID-19 have faster rate of decrease in eGFR after discharge
Tocilizumab Use Not Supported for Moderate-to-Severe COVID-19
Progression of COVID-19 up to day 14 did not differ with addition of tocilizumab to standard care in Phase 3 trial conducted in India
One in Five Health Care Workers Reports Mental Health Conditions
Review shows high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic
Biden Announces Plan to Buy 100 Million More Doses of J&J Vaccine
President has said that every American adult will have access to a vaccine by the end of May
